Exelderm (Ranbaxy Laboratories Inc.)


Welcome to the PulseAid listing for the Exelderm drug offered from Ranbaxy Laboratories Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ranbaxy Laboratories Inc.
NON-PROPRIETARY NAME: sulconazole nitrate
SUBSTANCE NAME: SULCONAZOLE NITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Azole Antifungal [EPC],Azoles [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-04-08
END MARKETING DATE: 0000-00-00


Exelderm HUMAN PRESCRIPTION DRUG Details:

Item DescriptionExelderm from Ranbaxy Laboratories Inc.
LABELER NAME: Ranbaxy Laboratories Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2009-04-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10631-100_0adaf1cf-a9ce-49fd-86fa-26baf90630d7
PRODUCT NDC: 10631-100
APPLICATION NUMBER: NDA018738

Other SULCONAZOLE NITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ranbaxy Laboratories Inc.Exelderm